{
    "body": "What are the indications for treatment with anti-hepcidin?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24159166", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24231125", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24175256"
    ], 
    "ideal_answer": [
        "improving anemia control\nanemia management in hemodialysis\niron-restricted anemias"
    ], 
    "exact_answer": [
        [
            "iron-restricted anemias"
        ], 
        [
            "anemia of inflammation"
        ], 
        [
            "anemia of cancer"
        ], 
        [
            "anemia of chronic kidney disease"
        ], 
        [
            "anemia of chronic disease"
        ]
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D064451"
    ], 
    "type": "list", 
    "id": "535d59349a4572de6f000009", 
    "snippets": [
        {
            "offsetInBeginSection": 694, 
            "offsetInEndSection": 748, 
            "text": "anti-hepcidin strategies for improving anemia control.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24231125", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1158, 
            "offsetInEndSection": 1228, 
            "text": "anti-hepcidin therapies may improve anemia management in hemodialysis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24175256", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 49, 
            "text": "Anti-hepcidin therapy for iron-restricted anemias", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24159166", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 73, 
            "offsetInEndSection": 219, 
            "text": "human anti-hepcidin antibody as a novel therapeutic for iron-restricted anemias such as anemia of inflammation, cancer, or chronic kidney disease ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24159166", 
            "endSection": "abstract"
        }
    ]
}